Year: 2016
Type: dissertation
Abstract: Acute myeloid leukemia (AML) is a malignant hematologic disease and the acute leukemia with the highest incidence among adults. The therapeutic obstacles result from the heterogeneity, the aggressive course, chemoresistance and relapse of the disease. In the bone marrow both normal hematopoiesis as well as malignant transformation of hematopoietic precursors takes place. Numerous studies demonstrate the protective effects of bone marrow stroma on AML cells. Stromal contact escapes malignant cells from spontaneous and therapy-induced apoptosis and promotes their survival and proliferation. The bone marrow stroma affects different malignant aspects and thereby consequently pathogenesis and the progression of the disease. An important malignant feature is the modified metabolism with induced aerobic glycolysis (”Warburg effect“). This metabolic reprogramming is linked to chemoresistance of tumor cells. In the context of this work we analyzed the impact of the bone marrow stroma on the metabolism of AML blasts. In vitro stromal contact induces increased expression of glucose transporters as wells as higher glucose uptake and upregulation of glycolytic genes and therefore a metabolic reprogramming towards aerobic glycolysis in tumor cells. Ex vivo experiments corroborate our results: AML cells purified from bone marrow exhibit higher glycolytic activity as compared to their counterparts from peripheral blood. Although stromal contact promoted chemoresistance, it increased the AML cells‘ sensitivity towards targeting glycolysis. Furthermore stromal contact promotes activity of mechanistic target of rapamycin (mTOR) in AML cells. This mechanism is controlled by the stroma-secreted chemokine CXCL12 which binds to the CXCR4-receptor on the AML cells. Using a mTOR inhibitor, a CXCR4 antagonist and gene silencing of stromal CXCL12 expression we were able to inhibit the stroma-induced ”Warburg effect“ in AML cells. Disruption of tumor-stroma interactions and the identified metabolic signaling pathways could be relevant targets for AML-therapy, to inhibit the protective effect of the bone marrow stroma and promote the sensitivity of AML cells towards therapeutics.
Author: Braun, Martina
Institution: Friedrich-Alexander-Universität Erlangen-Nürnberg
Language: German
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7037355558
